4//SEC Filing
Duncan Gregory Scott 4
Accession 0001415889-22-007076
CIK 0001818844other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 1:38 PM ET
Size
5.3 KB
Accession
0001415889-22-007076
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2022-06-23+90,000→ 90,000 totalExercise: $4.23Exp: 2032-06-23→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests one-third on June 23, 2023 and 1/24th monthly thereafter.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001831127
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 1:38 PM ET
- Size
- 5.3 KB